Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
PROGENICS PHARMACEUTICALS INC
| Metric | PROGENICS PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 43 / 100 |
| Revenue (latest) | $4M |
| Net income (latest) | −$69M |
| Operating margin | −426.0% |
| Net margin | −1601.3% |
| Return on equity | −147.3% |
| Return on assets | −57.4% |
| Return on capital (ROCE) | −18.7% |
| Debt / equity | 1.57× |
| Revenue growth (YoY) | 34.2% |
| Altman Z″ (distress) | -16.56 |
| Accruals / assets | 5.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.